Related Experiment Video

Updated: Jan 22, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.3K

Using machine learning to predict one-year cardiovascular events in patients with severe dilated cardiomyopathy

Rui Chen1, Aijia Lu2, Jingjing Wang1

  • 1Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong Province, China; School of Medicine, South China University of Technology, Guangzhou, Guangdong Province, China.

European Journal of Radiology
|July 17, 2019
PubMed

Insights

Machine learning effectively predicts 1-year cardiovascular events in severe dilated cardiomyopathy (DCM) patients. This tool aids clinicians in risk stratification and patient management for improved outcomes.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Machine Learning

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure with poor prognosis.
  • Patients with severe DCM and low ejection fraction face short-term adverse outcomes.
  • Accurate risk stratification is crucial for managing DCM patients.

Purpose of the Study:

  • To develop and validate a machine learning (ML) model for predicting 1-year cardiovascular events in severe DCM patients.
  • To identify key clinical features associated with cardiovascular events in this population.
  • To assist clinicians in risk stratification and patient management strategies.

Main Methods:

  • A naive Bayes classifier was trained on data from 98 severe DCM patients (LVEF < 35%).
  • Thirty-two clinical features were analyzed, with significant predictors selected using Information Gain (IG).
  • Model performance was assessed using 10-fold cross-validation and the area under the receiver operating characteristic curve (AUC).

Main Results:

  • The ML model achieved a high predictive performance with an AUC of 0.887.
  • Key predictors for cardiovascular events included left atrial size (IG=0.240), QRS duration (IG=0.200), and systolic blood pressure (IG=0.151).
  • Twenty-two out of 98 patients experienced a cardiovascular event within the 1-year follow-up.

Conclusions:

  • Machine learning provides an effective method for predicting 1-year cardiovascular risk in severe DCM.
  • The identified clinical features can guide risk stratification efforts.
  • This ML approach holds potential for future clinical decision support in DCM management.
Abstract

Keywords:
Machine learningPrognostic valueSevere dilated cardiomyopathy

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.7K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

497

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
492
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
488
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
433
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
521
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
321
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
361